Streetbeat News

Equity Actions

MCD

During a conference call, a McDonald's executive stated that the company is gaining market share among both middle- and higher-income consumers, while maintaining its share among lower-income consumers.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:14 pm

CARG

CarGurus (NASDAQ:CARG) has announced the appointment of Elisa Palazzo as its Chief Financial Officer (CFO), effective from December 4, 2023. Palazzo, who currently serves as Deputy CFO and Senior Vice President of Finance at Talkspace, will lead financial operations and strategy at CarGurus. The move is part of the company's goal to build a powerful transaction-enabled destination that supports the full lifecycle of a vehicle transaction.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:09 pm

INVH

Oppenheimer analyst Tyler Batory has upgraded Invitation Homes (NYSE:INVH) from Perform to Outperform and set a new price target of $35.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:06 pm

CVX

B of A Securities analyst Doug Leggate has upgraded Chevron (NYSE:CVX) from Neutral to Buy and raised the price target from $190 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 1:04 pm

WDC

Western Digital Corp (WDC) reported a Q1 FY23 revenue decline of 26% YoY to $2.75 billion, beating the consensus of $2.65 billion. The company's board approved a plan to separate its HDD and Flash businesses. WDC sees Q2 FY23 revenue of $2.85 billion - $3.05 billion, compared to the consensus of $2.92 billion. WDC shares traded higher by 13.20% at $44.11 premarket on the last check Monday.

Portfolio Pulse from Anusuya Lahiri

October 30, 2023 | 1:00 pm

ALZN

Alzamend Neuro has announced a reverse stock split, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:49 pm

VYNE

VYNE Therapeutics announced a private placement of $88 million and data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with nonsegmental vitiligo. This has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:48 pm

SNBR

Blue Clay Capital, long-term shareholders of Sleep Number Corporation (NASDAQ:SNBR), have sent a letter to the company's board urging them to immediately elect three Stadium Capital board representatives. They cite poor management decisions, ineffective strategic decisions, and a lack of accountability as reasons for Sleep Number's 46% decline since 2015, compared to a 161% gain for Tempur-Pedic and 125% gain for the S&P 500. They also express concerns about misallocation of capital and resources, untimely stock repurchases, and excessive executive compensation.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:47 pm

CNDT

Conduent Incorporated (NASDAQ:CNDT) has announced Conduent CXNow, a digital Customer Experience-as-a-Service offering for commercial and government clients. The solution, designed for mid- to large-sized businesses and government agencies, leverages artificial intelligence to provide chatbots, sentiment analysis, and predictive engagement. The cloud-based solution is flexible and scalable, aiming to meet the needs of a broad range of industries.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:44 pm

VRDN

Viridian Therapeutics has appointed Stephen Mahoney as its new CEO and announced a $185M private placement financing. The company also unveiled its next-generation FcRn inhibitor programs for autoimmune diseases. Viridian's pipeline includes IGF-1R inhibitors for thyroid eye disease (TED) and FcRn inhibitors. The company expects to select its lead subcutaneous IGF-1R program by the end of 2023 and topline results from the first THRIVE Phase 3 clinical trial for intravenous VRDN-001 for active TED in mid-2024. The financing will extend the company's operating runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:38 pm